DOI:
10.1055/s-00029029
Journal of Pediatric Intensive Care
LinksClose Window
References
Panacek EA, Marshall JC, Albertson TE. , et al.
Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels.
Crit Care Med 2004;
32 (11) 2173-2182
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.